You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Statement Concerning the Recent Ruling Issued by the PTO’s Patent Trial and Appeal Board

<p>
&quot;It is disappointing that the PTO&rsquo;s&nbsp;Patent Trial and Appeal Board (PTAB) failed to properly assess the important issues raised by this motion. This cursory and erroneous ruling reinforces the immediate need for Congress and the PTO leadership to take clear and decisive action to prevent any further misuse and abuse of the Inter Partes Review process by hedge funds, extortionists and other questionable entities seeking to undermine it for their own financial benefit.&quot;&nbsp;</p>

Washington, D.C. (September 28, 2015) – The following statement may be attributed to the Biotechnology Industry Organization (BIO):

"It is disappointing that the PTO’s Patent Trial and Appeal Board (PTAB) failed to properly assess the important issues raised by this motion. This cursory and erroneous ruling reinforces the immediate need for Congress and the PTO leadership to take clear and decisive action to prevent any further misuse and abuse of the Inter Partes Review process by hedge funds, extortionists and other questionable entities seeking to undermine it for their own financial benefit."

 

Upcoming BIO Events 
 

PMC/BIO Solutions Summit
October 14, 2015
Washington, D.C.

BIO Latin America Conference
October 14-16, 2015
Rio de Janeiro, Brazil

BIO-Europe
November 2-4, 2015
Munich, Germany

BIO Investor Forum
October 20-21, 2015
San Francisco, Calif.

BIO CEO & Investor Conference
February 8-9, 2016
New York, New York

BIO IP Counsels Committee Conference
November 16-18, 2015
Cary/Raleigh, NC

BIO International Convention
June 6-9, 2016
San Francisco, Calif.

13th Annual BIO Asia International Conference
March 15-16, 2016
Tokyo, Japan

 

 

###